NI
FATE icon

Numeric Investors’s Fate Therapeutics FATE Stock Holding History

Numeric Investors’s Portfolio FATE Stock Details FATE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$474K Buy
77,563
+33,463
+76% +$149K ﹤0.01% 905
2017
Q3 		$175K Buy
+44,100
New +$150K ﹤0.01% 1041
2015
Q3 		– Sell
-18,742
Closed -$121K – 1032
2015
Q2 		$121K Buy
+18,742
New +$112K ﹤0.01% 899

Other funds holding FATE

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
PVMCV
Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
ECM
Endurant Capital Management San Mateo, California $17.4M AUM 7.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Numeric Investors's FATE Position: Q4 2017 in Review

Numeric Investors increased its Fate Therapeutics (FATE) stake by 76% in Q4 2017, buying an estimated $149K and bringing the position to 77,563 shares worth $474K. The position accounts for ﹤0.01% of the portfolio, ranked #905.

Numeric Investors first reported a position in FATE in Q2 2015 and has held it in 3 quarters since. 78 funds tracked by Wall St. Rank hold FATE as of Q4 2017.

  • Numeric Investors held 77,563 shares of Fate Therapeutics worth $474K as of Q4 2017.
  • Numeric Investors bought 33,463 Fate Therapeutics shares in Q4 2017, an estimated $149K.
  • Fate Therapeutics made up ﹤0.01% of Numeric Investors's portfolio in Q4 2017, its #905 holding.
  • Numeric Investors first reported a position in Fate Therapeutics in Q2 2015 and has held it in 3 quarters since.
  • 78 funds tracked by Wall St. Rank held Fate Therapeutics as of Q4 2017.

Based on Numeric Investors's 13F filing for Q4 2017, filed 14 Feb 2018.